Parkwood LLC Day One Biopharmaceuticals, Inc. Transaction History

Parkwood LLC

  • $1.42 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
BUY
$12.75 - $23.41 $13,107 - $24,065
1,028 Added 5.31%
20,381 $272,000
Q4 2022

Feb 14, 2023
BUY
$18.77 - $22.0 $16,480 - $19,316
878 Added 4.75%
19,353 $416,000
Q3 2022

Nov 14, 2022
BUY
$16.44 - $26.57 $303,729 - $490,880
18,475 New
18,475 $370,000

Others Institutions Holding DAWN

# of Institutions
178
Shares Held
84M
Call Options Held
144K
Put Options Held
218K
View Full List

About Day One Biopharmaceuticals, Inc.

DAWN Quotes by TradingView
  • Ticker DAWN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 73,461,104
  • Market Cap $986M
  • Description
  • Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric pa...
More about DAWN
Track This Portfolio

Track Parkwood LLC Portfolio

Follow Parkwood LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parkwood LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parkwood LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email